Page last updated: 2024-08-24

n,n-carbonyldiimidazole and lysine

n,n-carbonyldiimidazole has been researched along with lysine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abedin, MR; Aiardo, R; Barua, D; Barua, S; Powers, K	1

Other Studies

1 other study(ies) available for n,n-carbonyldiimidazole and lysine

Article	Year
Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells. Scientific reports, 2021, 04-01, Volume: 11, Issue:1 Topics: Antibodies; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Inhibitory Concentration 50; Lysine; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Paclitaxel; Receptor, ErbB-2; Trastuzumab	2021

Article

Year

Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.

Scientific reports, 2021, 04-01, Volume: 11, Issue:1

Topics: Antibodies; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Inhibitory Concentration 50; Lysine; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Paclitaxel; Receptor, ErbB-2; Trastuzumab

2021